Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

IMAC logo
$1.12 +0.02 (+1.82%)
(As of 12/19/2024 ET)

About IMAC Stock (NASDAQ:IMAC)

Key Stats

Today's Range
$1.07
$1.12
50-Day Range
$1.01
$1.39
52-Week Range
$0.75
$1.65
Volume
64,471 shs
Average Volume
708,132 shs
Market Capitalization
$29.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

The Mac in 2025: Small updates and big hopes
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
When will Apple stop supporting Intel Macs?
iMac Pro Launched Seven Years Ago Today
Microsoft Discontinues iMac Rival Surface Studio 2+
See More Headlines

IMAC Stock Analysis - Frequently Asked Questions

IMAC's stock was trading at $2.21 at the start of the year. Since then, IMAC stock has decreased by 49.3% and is now trading at $1.12.
View the best growth stocks for 2024 here
.

IMAC Holdings, Inc. (NASDAQ:IMAC) announced its quarterly earnings data on Thursday, April, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. IMAC had a negative net margin of 75.40% and a negative trailing twelve-month return on equity of 52.17%.

IMAC (IMAC) raised $4 million in an IPO on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMAC investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), iBio (IBIO), VBI Vaccines (VBIV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Energy Transfer (ET).

Company Calendar

Last Earnings
4/14/2022
Today
12/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Specialty Outpatient Clinics
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$15.22 million
Book Value
$0.69 per share

Miscellaneous

Free Float
23,837,000
Market Cap
$29.66 million
Optionable
Not Optionable
Beta
-0.88
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:IMAC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners